[Source: Research & Innovation]

To ensure the right person takes an Ebola trial vaccine at the right time in Sierra Leone, an EU-industry funded project is employing a combination of low-tech and high-tech community engagement strategies. Today, 450 adults and 96 adolescents are successfully enrolled in a two-stage vaccine trial.
from EUROPA - Syndicated Research News Feed http://ift.tt/2uf2CNA
via
IFTTT
No comments:
Post a Comment